Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
RCKT holding history
Rocket Pharmaceuticals, Inc. in every 13F filed by Prosight Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings
- Shares (Q2 2026)
- 700,000
- Value
- $2.39M
- % of portfolio
- 0.4%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 700,000 | $2.39M | 0.4% | +16,144+2.4% | Added | Holders |
| Q1 2026 | 683,856 | $2.45M | 0.4% | −60,086−8.1% | Reduced | Holders |
| Q4 2025 | 743,942 | $2.61M | 0.5% | −524,023−41.3% | Reduced | Holders |
| Q3 2025 | 1,267,965 | $4.13M | 1.0% | −312,623−19.8% | Reduced | Holders |
| Q2 2025 | 1,580,588 | $3.87M | 0.9% | +100,588+6.8% | Added | Holders |
| Q1 2025 | 1,480,000 | $9.87M | 3.2% | +391,294+35.9% | Added | Holders |
| Q4 2024 | 1,088,706 | $13.7M | 3.8% | +929,337+583.1% | Added | Holders |
| Q3 2024 | 159,369 | $2.94M | 0.7% | +159,369 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −32,193−100.0% | Sold out | Holders |
| Q4 2022 | 32,193 | $630.0K | 0.4% | −167,807−83.9% | Reduced | Holders |
| Q3 2022 | 200,000 | $3.19M | 1.8% | −76,802−27.7% | Reduced | Holders |
| Q2 2022 | 276,802 | $3.81M | 3.1% | +73,534+36.2% | Added | Holders |
| Q1 2022 | 203,268 | $3.22M | 2.3% | +74,563+57.9% | Added | Holders |
| Q4 2021 | 128,705 | $2.81M | 1.9% | +128,705 | New | Holders |